GEODE CAPITAL MANAGEMENT, LLC
Position in VRCA — Verrica Pharmaceuticals Inc.
CIK 1214717
BOSTON, MA
Position in VRCA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$845,538
+$110,668 QoQ
Shares Held
138,160
-0.5% QoQ
Ownership
0.804%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRCA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. VRCA ranks #329 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VRCA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $845,538 | 138,160 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $734,870 | 138,917 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $562,246 | 67,659 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $291,609 | 67,659 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $342,462 | 646,156 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $450,169 | 1,018,486 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $334,088 | 477,269 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $660,445 | 455,480 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,377,908 | 463,362 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,659,909 | 449,309 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,145,235 | 429,677 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,619,229 | 416,790 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,241,685 | 388,507 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,175,739 | 180,883 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $448,148 | 162,963 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $438,686 | 150,235 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $232,596 | 121,144 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,763,097 | 217,398 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,995,304 | 217,828 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,975,862 | 238,069 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,406,674 | 212,980 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,017,243 | 199,158 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,126,656 | 184,766 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,442,140 | 186,323 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,174,684 | 197,519 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,968,110 | 180,065 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||